Best timing for the Tdap vaccine during pregnancy
Part of Infections, Lungs & breathing clinical trials.
This study tests when during pregnancy it is best to get the Tdap (whooping cough) vaccine. It aims to protect both mother and baby from whooping cough in the first months after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and plan to get the Tdap vaccine.
- You are willing to be in the study until 6 months after giving birth.
- You have not had a pertussis-containing vaccine in the last 5 years.
- You do not have a serious immune system condition (like HIV) or take high-dose steroids.
- You have no severe mental health condition or previous bad reaction to a vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
This study looks at how babies’ immune systems develop in early life and how they respond to immunization. It compares preterm infants with full-term infants whose mothers received Tdap during pregnancy, to learn what protection and immune responses to expect.
This trial tests different ways to help partners of pregnant people get the Tdap vaccine (a shot that protects against tetanus, diphtheria, and whooping cough). The goal is to find the best way to increase vaccination rates among partners, which can help protect the newborn from whooping cough.
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.
This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.
Hear when a new Pertussis (Whooping Cough) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.